期刊文献+

纳米羟基磷灰石表面修饰及其转染细胞的研究 被引量:2

Surface modification of Nano-hydroxyapatite and its application to cell transfection
原文传递
导出
摘要 目的:探讨羟基磷灰石-聚乙烯亚胺(nHA-PEI 10KD)纳米颗粒的癌细胞基因转染效率。方法:通过透射电子显微镜(TEM)观察HA-PE(I10KD)纳米颗粒的形态及粒径,Zeta电位仪测定nHA-PEI和HA在酸、碱、中性环境中的电位,用琼脂糖凝胶电泳检测nHAP-PE(I10KD)与DNA结合的能力,MTT比色法检测nHAP-PE(I10KD)对HepG2细胞的毒性,选用增强型绿色荧光蛋白质粒pEGFP1与nHA-PEI结合后,分别转染真核细胞HepG2、Hela、SW620,计算其转染率。结果:nHA-PE(I10KD)分散程度好,粒径60-80nm,在PH7.2时,Zeta电位42.87mV,能转染实验中的细胞,转然效果最好的是HepG2细胞,其次Hela、SW620,转染率高于PEI(10KD)、nHA,但低于脂质体。结论:通过阳离子PEI修饰HA,可有效将增强型绿色荧光蛋白质粒转入HepG2细胞,HA-PE(I10KD)纳米颗粒复合物有望成为基因传递的有效载体。 Objective:To investigate the efficiency of gene transfection mediated by hydroxyapatite-polyethyleneimine(nHA-PEI 10KD) nanoparticles in cancer cells.Methods: The shape and size of HA-PEI nano-particle were observed by Transmission Electron Microscopy(TEM),The potential of nHA-PEI and HA in acid,alkaliand neutral conditions were measured by Zeta Potential Instrument.DNA binding capacity of nHAP-PEI(10KD) was detected by agarose gel electrophoresis,MTT assy was performed to evaluate the toxicity ofnHAP-PEI (10KD) to HepG2 cells. The combinations of enhanced green fluorescent protein plasmid pE(3FP1 and nHA-PEI were transfected into HepG2, Hela and SW620 cells, and the transfection efficiency was evaluated by Flow Cytomea'y. Remtlts: nHA-PEI (10KD) are in high dispersion and the size of particle is 60 - 80nm. At PH of 7.2, Zeta Potential of 42.87mV, nHA-PEI transfects into experiment cells, especially in HepG2 cells, followed by Hela, SW620.The transfection efficiency ofnHA-PEI was higher than PEI (10) and nHA, but lower than liposomes. Conclusions: The modified HA by PEI cation can potentiate the transfection of enhanced green fluorescent protein plasmid into HepG2 cells. HA-PEI (10KD) composite nanoparticles are expected to become an effective gene delivery vector.
出处 《现代生物医学进展》 CAS 2009年第19期3669-3672,3695,共5页 Progress in Modern Biomedicine
关键词 羟基磷灰石 聚乙烯亚胺 基因载体 转染效率 hydroxyapatite polyethylenimine gene vector transfection efficiency
  • 相关文献

参考文献17

  • 1Kohn DB, Sadelain M, Glorioso JC. Occurrence of leukaemia following gene therapy of X-linked SCID[J]. Nat Rev Cancer, 2003,3 (7):477-488.
  • 2Marshall E. Gene therapy a suspect in leukemia-like disease [J]. Science, 2002, 298(5591):34-35.
  • 3Vijayanathan V, Thomas T, Thomas TJ. DNA nanoparticles and development of DNA delivery vehicles for gene therapy[J], Biochem, 2002, 41(48):14085-14094.
  • 4Krisanapiboon A, Buranapanitkit B, Ounqbho K. Biocompatability of hydroxyapatite composite as a local drug delivery system[J]. J Orthop Surg, 2006,14(3):315-318.
  • 5Hing KA, Revell PA, Smith N, et al. Effects of silicon level on rate, quality and progession of bone healing within silicate-substituted porous hydroxyapatite scaffolds [J]. Biomaterials, 2006, 27 (29): 5014-5026.
  • 6Wataha JC, Hanks CT, Craig RG. In vitro effects of metal ions on celluar metabolism and the correlation between these effects and the uptade of the ions. [J]. Biomed Mater Res, 1994;28:427.
  • 7Chalfie M, Tu Y, Euskirchen G, et al. Green fluorescent protein as a marker for gene expression[J]. Science, 1994,263(5148): 802-805.
  • 8Xu ZP, Walker TL, Liu KL, et al. Layered double hydroxide nanoparticles as cellular delivery vectors ofsupercoiled plasmid DNA[J]. Int J Nanomedicine, 2007, 2 (2) : 163-174.
  • 9Feng L, Li S, Yah Y. et al. The effect of CaCO3 and TiO2 nanometer particles on A549 and L929 cell[J]. Bioceramics, 2000,13:325.
  • 10Prabhaa S, Zhoua WZ, Panyama J, et al. Size-dependency of nanoparticle-mediated gene transfection:studies with fractionated nanoprticles[J]. Int J Pharm, 2002, 244(1-2): 105-115.

同被引文献21

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部